Reduced levels of SDC2 in TASCs was associated with a significant decrease in tumour growth compared to that of shControl tumours and reduced levels of TGFβ‐regulated genes, for example, SMAD7 (Figure 3B). This evidence concerns the gene SMAD7 and neoplasm.